title: Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis.
abstract: BACKGROUND
  Lipopolysaccharide-binding protein (LBP) is a class 1 acute-phase protein that binds and transfers bacterial lipopolysaccharide (LPS). This study investigated the clinical value of measuring LBP for stratifying biochemical severity in acute pancreatitis by using a recently developed fully automated assay technique.
  
  
  METHODS
  We studied 71 patients with acute pancreatitis of whom 41 presented with a necrotizing course. Necrotizing pancreatitis was associated with pancreatic infections in 21 patients and with multiorgan dysfunction syndrome (MODS) in 18 patients. Serum LBP was measured for 14 days by a fully automated immunoassay and CRP was assessed on a daily routine basis.
  
  
  RESULTS
  The relative quantitative systemic release of LBP was lower than that observed for CRP; however, the two parameters revealed similar dynamics, with a maximum increase in acute pancreatitis around the fourth day after onset of symptoms. As observed for CRP, LBP was significantly higher in patients who developed complications such as necrosis, pancreatic infections, single or combined MODS than in those who did not. Multiple regression analysis revealed that pulmonary failure and MODS were independent variables associated with enhanced LBP release, while the development of necrosis, pancreatic infections and MODS were the corresponding variables for increased CRP levels.
  
  
  CONCLUSIONS
  Systemic LBP concentrations are significantly elevated in acute pancreatitis and closely correlate with overall disease severity. However, compared with CRP, LBP does not contribute to an improved severity stratification in acute pancreatitis.
authors.affiliation: Department of General, Visceral, and Vascular Surgery, University of the Saarland, Kirrberger Strasse, 66421 Homburg/Saar, Germany. bettina.rau@uniklinik-saarland.de
authors.forename: Bettina
authors.initials: B
authors.lastname: Rau
authors.forename: Gerald
authors.initials: G
authors.lastname: Steinbach
authors.forename: Colin M
authors.initials: CM
authors.lastname: Krüger
authors.forename: Katja
authors.initials: K
authors.lastname: Baumgart
authors.forename: Martin
authors.initials: M
authors.lastname: Schilling
authors.forename: Hans G
authors.initials: HG
authors.lastname: Beger
mesh_terms: D000208:Acute Disease; D000209:Acute-Phase Proteins / Q000032:analysis*; D002097:C-Reactive Protein / Q000032:analysis; D002352:Carrier Proteins / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008562:Membrane Glycoproteins; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000453:epidemiology; D010195:Pancreatitis / Q000097:blood* / Q000175:diagnosis; D019283:Pancreatitis, Acute Necrotizing / Q000097:blood* / Q000175:diagnosis; D018805:Sepsis / Q000453:epidemiology; D012720:Severity of Illness Index; D000099231:Lipopolysaccharide-Binding Protein
chemical_list: D000209:Acute-Phase Proteins; D002097:C-Reactive Protein; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D000099231:Lipopolysaccharide-Binding Protein